Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

GlaxoSmithKline Consumer Healthcare
980 Great West Road, Brentford, Middlesex, TW8 9GS
Telephone: +44 (0)20 8047 5000
Medical Information Direct Line: +44 (0)20 8047 2500
Medical Information e-mail: customer.relations@gsk.com
Customer Care direct line: +44 (0)20 8047 2700
Medical Information Fax: +44 (0)20 8047 6860

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 10/01/2012
SPC Day & Night Nurse Capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 10/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to section 6. 5 - Nature and Contents of Container
Date of revision of text on the SPC:   14-Dec-2011
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Section 6.5 updated to correct the specification of the blister foil from '250 micron PVC/40gsm PVDC blister tray' to '250 micron PVC/60gsm PVDC blister tray'
Updated on 18/10/2011 and displayed until 10/01/2012
Reasons for adding or updating:
  • Change to section 4.2 - Posology and method of administration
Date of revision of text on the SPC:   11-Nov-2010
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Section 4.2 - addition of further warnings:-

Do not exceed stated dose
Do not use for longer than 3 days without medical advice
Allow 4 hours between the last dose of Day Nurse and the dose of Night Nurse
Not to be taken with any other cough, cold or antihistamine containing products
Updated on 26/08/2009 and displayed until 18/10/2011
Reasons for adding or updating:
  • Change to section 6.1 - List of Excipients
Date of revision of text on the SPC:   14-Aug-2009
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
In section 6.1, Erythrosine (E127) has been removed from the capsule shell.
Updated on 04/03/2008 and displayed until 26/08/2009
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable Effects
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   02/2008
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Section 4.8 Changed to include hypersensitivity reactions and anaphylaxis.
Section 10 Updated to 14/02/08
Updated on 23/04/2007 and displayed until 04/03/2008
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 20/04/2007 and displayed until 23/04/2007
Reasons for adding or updating:
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.9 - Overdose
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   02/2007
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Section 4.5 Update BAN cholestyramine to rINN colestyramine
Section 4.9 Update to include generic overdose statements for paracetamol, pseudoephedrine hydrochloride, promethazine and dextromethorphan/pholcodine
Updated on 17/05/2005 and displayed until 20/04/2007
Reasons for adding or updating:
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC